OneMedNet advances commercial launch of Palantir Foundry-powered real-world data platform

Reuters
02/27
<a href="https://laohu8.com/S/ONMD">OneMedNet</a> advances commercial launch of <a href="https://laohu8.com/S/PLTR">Palantir</a> Foundry-powered real-world data platform

OneMedNet Corporation said it is entering the next phase of its commercial launch for its Real-World Data platform powered by Palantir Foundry, and is working to convert customer evaluations into paid subscriptions following a Nov. 10, 2025 demonstration of live feeds, subscription access and AI-driven search. The company reported early evaluation feedback citing analytical depth across integrated clinical and longitudinal datasets, faster cohort feasibility and discovery, streamlined workflows, and quicker onboarding of data partners. OneMedNet said it is expanding subscription contracts, including multi-year deals representing millions in incremental recurring revenue, and that its iRWD network now includes more than 2,130 healthcare sites. The company also said datasets on the platform are continuously connected to sources in real time, providing longitudinal access spanning more than 20 years of historical data and extending three years forward.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onemednet Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602270850PRIMZONEFULLFEED9662683) on February 27, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10